STATUS OF HBSAG PREVALENCE IN A DENTAL COMMUNITY – A CROSS-SECTIONAL STUDY
Keywords:
Dental health care workers, Hepatitis B surface antigen, Hepatitis B, SeroprevalenceAbstract
Background: Hepatitis-B is one of the major public health problems and is a well-recognized risk factor amongst healthcare workers due to their occupational exposure. As such, it is of prime importance to understand the risk factors and the measures needed to avoid or overcome them.
Aim: To estimate the prevalence of Hepatitis B surface antigen amongst dental staff members and students.
Methods: A total of 462 Healthcare Workers were grouped in 5 categories according to the years of clinical exposure. After institutional ethical clearance and individual written consent, all Healthcare Workers were explained about the objective of the study and were asked to fill a standard questionnaire regarding their personal health information and vaccination status. Their blood samples were tested by Enzyme Linked Immunosorbent assay for Hepatitis B surface antigen.
Results: 9 (1.94%) Healthcare Workers were found to be positive for Hepatitis B surface antigen. A statistically significant correlation was found between the years of clinical exposure and the seroprevalence of Hepatitis B surface antigen (p<0.05).
Conclusion: For an educational institute and hospital, the prevalence rate is considerably high and it reflects upon the proportionate increase in exposure to virus with clinical exposure. It also points towards the low level of awareness regarding occupational risk of Hepatitis B among Healthcare Workers. This calls upon an urgent and mandatory need to incorporate Hepatitis B Virus vaccination amongst Healthcare Workers at a sizeable scale.
References
I. Rajani M, Jais M. Magnitude and pattern of hepatitis B infection in clinically suspected infectious hepatitis at a tertiary care hospital in urban India. Journal of Global Infectious Diseases. 2014;6(3):105.
II. Alese OO, Alese MO, Ohunakin A, Oluyide PO. Seroprevalence of hepatitis B surface antigen and occupational risk factors among health care workers in Ekiti State, Nigeria. J Clin Diagn Res. 2016;10(2):LC16–LC18.
III. Negero A, Sisay Z, Medhin G. Prevalence of Hepatitis B surface antigen (HBsAg) among visitors of Shashemene General Hospital voluntary counseling and testing center. BMC Research Notes. 2011;4(1):35.
IV. Puri P. Tackling the Hepatitis B Disease Burden in India. Journal of Clinical and Experimental Hepatology. 2014;4(4):312-319.
V. Robinson WS. Hepatitis B virus and hepatitis D virus. In: Mandell GL, Bennett JE, Dolin R, editors. Principles and Practice of Infectious Diseases. 4th ed. New York, Churchill Livingstone, 1995:1406-39.
VI. Holmberg S, Suryaprasad A, Ward J. Updated CDC recommendations for the management of hepatitis B virus-infected health-care providers and students. Atlanta, GA: U.S. Department of Health and Human Services, Centers for Disease Control and Prevention; 2012.
VII. Singh S, Singhal V, Bora D. Hepatitis B in health care workers: Indian scenario. Journal of Laboratory Physicians. 2009;1(2):41.
VIII. Weinbaum C, Mast E, Ward J. Recommendations for identification and public health management of persons with chronic hepatitis B virus infection. Hepatology. 2009;49(S5):S35-S44.
IX. Rizzetto M, Ciancio A. Chronic HBV-related liver disease. Molecular Aspects of Medicine. 2008;29(1-2):72-84.
X. Lee W. Hepatitis B Virus Infection. New England Journal of Medicine. 1997;337(24):1733-1745.
XI. Moyer LA, Mast EE. Hepatitis B: virology, epidemiology, disease, and prevention, and an overview of viral Hepatitis. Am J Prev Med. 1994;10:45-55.
XII. Daw MA, Siala IM, Warfalli MM, Muftah MI. Seroepidemiology of Hepatitis B virus markers among hospital health care workers - Analysis of certain potential risk factors. Saudi Med J. 2000;2:1157-60.
XIII. Karpuch J, Scapa E, Eshchar J, Waron M, Bar-Shany S, Shwartz T. Vaccination against Hepatitis B in a general hospital in Israel: Antibody level before vaccination and immunogenicity of vaccine. Isr J Med Sci. 1993;29:449-52.
XIV. Newsom DH, Kiwanuka JP. Needle-stick injuries in a Ugandan teaching hospital. Ann Trop Med Parasitol. 2002;96:517-22.
XV. Schiff ER, Medina MD, Kline SN, Johnson GR, Chan YK, Shorey J et al. Veterans administration co-operative study on Hepatitis and dentistry. J Am Dent Assoc. 1986;113:390-6.
XVI. Singhal V, Bora D, Singh S (2011) Prevalence of Hepatitis B Virus Infection in Healthcare Workers of a Tertiary Care Centre in India and Their Vaccination Status. J Vaccines Vaccin. 2011,2:2.
XVII. Morgan M, Keefe B. Diagnosis and treatment of chronic Hepatitis B: 2009 update. Minerva Gastroenterol Dietol. 2009;55:5-22.
XVIII. McMahon BJ. Selecting appropriate management strategies for chronic Hepatitis B: Who to treat. Am J Gastroenterol. 2006;101:7-12.
XIX. Elavia AJ, Banker DD. Hepatitis B virus infection in hospital personnel. Natl Med J India. 1992;5:265–8.
XX. Kardam P, Mehendiratta M, Rehani S, Kumra M. Seroprevalence and vaccination status of hepatitis B amongst dental health-care workers in North India. Indian Journal of Gastroenterology. 2013;33(2):190-191.
XXI. Taishete S, Chowdhary A. Seroepidemiological survey of health care workers in Maharashtra. Indian Journal of Medical Microbiology. 2016;34(2):237.
XXII. Marcellin P. Hepatitis B and hepatitis C in 2009. Liver International. 2009;29:1-8.
XXIII. World Health Organization. Hepatitis B Fact sheet No 204 (Revised October 2000). Available from: URL: http://www.who.int/mediacentre/factsheets/fs204/en/.
XXIV. Mahoney FJ, Stewart K, Hu H, Coleman P, Alter MJ. Progress toward the elimination of hepatitis B virus transmission among health care workers in the United States. Arch Intern Med. 1997;157:2601-5.
XXV. Nasir K, Khan KA, Kadri WM, Salim S, Tufail K, Sheikh HZ, Ali SA. Hepatitis B vaccination among health care workers and students of a medical college. J Pak Med Assoc. 2000;50:239-43.
XXVI. Doebbeling BN, Ferguson KJ, Kohout FJ. Predictors of Hepatitis B vaccine acceptance in health care workers. Med Care. 1996;34:58-72.
XXVII. Braka F, Nanyunja M, Makumbi I, Mbabazi W, Kasasa S, Lewis RF. Hepatitis B infection among health workers in Uganda: evidence of the need for health worker protection. Vaccine. 2006;24:6930-7.
XXVIII. Bonanni P, Bonaccorsi G. Vaccination against Hepatitis B in health care workers. Vaccine. 2001;19:2389–94.
XXIX. Westmoreland D, Player V, Heap DC, Hammond A. Immunization against Hepatitis B — what can we expect? Results of a survey of antibody response to immunization in persons 'at risk' of occupational exposure to hepatitis B. Epidemiol Infect. 1990; 104: 499–509.
XXX. Grosheide P, Van Damme P. Prevention and control of Hepatitis B in the community. In: Hallauer J, Kane M, McCloy E, editors. Communicable disease series No.1. The Viral Hepatitis Prevention Board Secretariat. Edegem (Belgium): Jacqmain Ltd.; 1996.
XXXI. Verma R, Khanna P, Prinja S, Rajput M, Chawla S, Bairwa M. Hepatitis B vaccine in the national immunization schedule - A preventive step in India. Human Vaccines. 2011;7:1387-8.
XXXII. West DJ, Calandra GB. Vaccine induced immunologic memory for Hepatitis B surface antigen: Implications for policy on booster vaccination. Vaccine. 1996;14:1019–27.
XXXIII. Updated U.S. Public Health Service guidelines for the management of occupational exposures to HBV, HCV, and HIV and recommendations for postexposure prophylaxis. Atlanta, GA: U.S. Dept. of Health and Human Services, Centers for Disease Control and Prevention (CDC); 2001.
Additional Files
Published
How to Cite
Issue
Section
License
Copyright (c) 2021 International Education and Research Journal (IERJ)
This work is licensed under a Creative Commons Attribution 4.0 International License.
